Real-World Efficacy, Safety, and Drug Retention of Anakinra and Canakinumab in Pediatric Colchicine-Resistant Familial Mediterranean Fever: Insights from a Single-Center Cohort.
This study evaluated the efficacy, safety, and drug retention of anakinra and canakinumab in pediatric patients with colchicine-resistant familial Mediterranean fever (cr-FMF) within a real-world cohort. This retrospective cohort study was conducted from June 2016 to April 2024,…